How the most comprehensive biomedical database will enable the discovery of new drug treatments скачать в хорошем качестве

How the most comprehensive biomedical database will enable the discovery of new drug treatments

A look at the UK Biobank and how it will enable the discovery of new drug treatments. Chair: Professor Naveed Sattar, Professor of Metabolic Medicine, University of Glasgow 00:06:25 'UK Biobank: large, deep, long and accessible' Professor Naomi Allen, Chief Scientist, UK Biobank, United Kingdom 00:21:12 'Identifying drug targets using UK Biobank exome sequencing data' Dr Abhishek Nag, Associate Principal Scientist, AstraZeneca 00:35:06 'Global collaboration and the use of the UK Biobank resource for drug discovery Dr Adrian Cortes, Scientific Director, GSK 00:50:45 'Leveraging UK Biobank for precision medicine-focused innovation in biotech' Dr Mary Helen Black, VP, Head of Human Genomics, Foresite Labs 01:06:31 'The value of large-scale proteomics for understanding mechanisms' Dr Chris Whelan, Director, Neuroscience Data Science at Johnson & Johnson 01:21:04 'Cloud-based computing for global collaboration and drug discovery' Dr Asha Collins, General Manager, Biobanks Data Analysis Platforms, DNAnexus 01:39:51 Questions & Answers